Latest News about SGIOY
Recent news which mentions SGIOY
Stocks That Hit 52-Week Lows On Tuesday
March 24, 2020
From Benzinga
The Daily Biotech Pulse: Amarin Gets Unanimous Backing For Vascepa Expansion, BeiGene's Blood Cancer Drug Gets Approval
November 15, 2019
From Benzinga
The Daily Biotech Pulse: FDA Panel Backs Shionogi's Antibiotic, Hepion Surges On Data Publication, Innate Pharma IPO
October 17, 2019
From Benzinga
From Benzinga
The Daily Biotech Pulse: ViiV's Long-Acting HIV Drug Meets Study Goal, Chinese Cheer For FibroGen, Retrophin Flunks Late-Stage Study
August 22, 2019
From Benzinga
Stocks That Fell Through 52-Week Lows Wednesday
August 07, 2019
From Benzinga
From Benzinga
From Benzinga
From Benzinga
The Daily Biotech Pulse: PhaseBio Gets Breakthrough Therapy Designation, FDA Shoots Down Zogenix Epilepsy Regulatory Filing
April 09, 2019
From Benzinga
Empire Analyst: Sell Sucampo Pharma, It Has 50% Downside
January 12, 2016
From Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.